MSC Exosomes for Alzheimer’s Disease and Parkinson’s Disease

Neurodegenerative diseases like Alzheimer’s and Parkinson’s represent some of the most urgent unmet needs in modern medicine. MSC-derived exosomes are among the most studied regenerative tools for neuroprotection and neural repair — with 6 published studies in BioRegenEx’s research library specifically addressing AD and PD mechanisms.

The Neurodegenerative Disease Crisis

Over 6.7 million Americans currently live with Alzheimer’s disease, and approximately 1 million live with Parkinson’s disease. Both conditions involve progressive neurodegeneration, neuroinflammation, and the loss of specific neural populations — processes that conventional pharmaceutical approaches have largely failed to halt or reverse.

MSC-derived exosomes represent a new class of biological tool that may address several of the root mechanisms in both diseases simultaneously, rather than targeting single molecular pathways.

Key Published Research: AD and PD

• Exosomes derived from MSCs repair a Parkinson’s disease model by inducing autophagy (PubMed)
• Exosomes: a novel therapeutic target for Alzheimer’s disease (PubMed)
• MSC-derived exosome: a promising alternative in the therapy of Alzheimer’s disease (PubMed)
• MSC-derived exosomes: a new possible therapeutic strategy for Parkinson’s disease (PubMed)
• The potential use of MSCs and their exosomes in Parkinson’s disease treatment (PubMed)
• View all neurodegenerative research in the BioRegenEx Research Library →

Mechanisms Being Investigated

• Autophagy induction: Studies show MSC exosomes activate cellular cleanup mechanisms that clear misfolded proteins like tau and alpha-synuclein.
• Neuroinflammation suppression: Exosome cargo modulates microglial activation states, reducing chronic CNS inflammation.
• Neurotrophic support: MSC exosomes deliver BDNF, GDNF, and other neurotrophic factors that support dopaminergic and cholinergic neuron survival.
• Mitochondrial rescue: Research indicates exosome-mediated improvement in mitochondrial function in aging and degenerating neurons.